Ex Parte Shannon - Page 3

               Appeal  2007-1998                                                                            
               Application 09/997,829                                                                       
               2.  Claim 106 stands rejected under 35 U.S.C. § 103(a) as unpatentable over                  
               the combination of Myer, Choi and Michal.                                                    
               3.  Claims 108-111 stand rejected under 35 U.S.C. § 103(a) as unpatentable                   
               over the combination of Myer, Choi, and Wijay.                                               
               4.  Claims 108-110 and 112 stand rejected under 35 U.S.C. § 103(a) as                        
               unpatentable over the combination of Myer, Choi and Becker.                                  
               5.  Claims 118 and 119 stand rejected under 35 U.S.C. § 103(a) as                            
               unpatentable over the combination of Myer, Choi, and Banas.                                  
                      We reverse.                                                                           

                                              DISCUSSION                                                    
                      Claims 103-105, 107, and 113-117 stand rejected under 35 U.S.C. §                     
               103(a) as unpatentable over the combination of Myer and Choi.                                
                      Claim 103 is drawn to an implantable drug eluting device.  Claims                     
               104, 105, 107, and 113-117 depend directly or indirectly from claim 103.                     
               The device of claim 103 has a compressed undeployed diameter and an                          
               expanded deployed diameter.  The device comprises three elements:                            
                      1.  a radially expandable stent comprising a generally cylindrical wall               
               surface and having a hollow bore extending longitudinally therethrough,                      
               wherein the generally cylindrical wall surface comprises a plurality of lateral              
               openings in the wall surface;                                                                
                      2. a coating comprising a polymer and a therapeutic substance                         
               disposed on the wall surface of the stent; and                                               
                      3. a tubular outer layer comprising expanded, sintered PTFE tape                      
               wound about the outer surface of said stent.                                                 



                                                     3                                                      

Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next

Last modified: September 9, 2013